NKCx Histopathological outcome* within 12 months after cervix cytology in 2018 |
621 Sundsvall |
Benign | CIN1 | CIN2 | CIN3 | AIS | Cancer | Other | PAD missing | Total | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cytology | Count | Pct | Count | Pct | Count | Pct | Count | Pct | Antal | Andel | Count | Pct | Count | Pct | Count | Pct | Count | Pct |
Benign sample | 46 | 0.4% | 3 | 0.0% | . | . | 1 | 0.0% | . | . | . | . | . | . | 10813 | 99.5% | 10863 | 100.0% |
ASCUS | 60 | 12.3% | 37 | 7.6% | . | . | 25 | 5.1% | 2 | 0.4% | . | . | 4 | 0.8% | 360 | 73.8% | 488 | 100.0% |
CIN1 | 61 | 28.1% | 42 | 19.4% | . | . | 21 | 9.7% | 1 | 0.5% | . | . | 5 | 2.3% | 87 | 40.1% | 217 | 100.0% |
Atypical glandular cells/AGC | 25 | 73.5% | 4 | 11.8% | . | . | 1 | 2.9% | 2 | 5.9% | 1 | 2.9% | 1 | 2.9% | . | . | 34 | 100.0% |
Unclear atypia | 14 | 66.7% | 1 | 4.8% | . | . | 4 | 19.0% | . | . | . | . | . | . | 2 | 9.5% | 21 | 100.0% |
ASC-H | 9 | 26.5% | 6 | 17.6% | . | . | 16 | 47.1% | 1 | 2.9% | . | . | 1 | 2.9% | 1 | 2.9% | 34 | 100.0% |
CIN2 | . | . | . | . | . | . | . | . | . | . | . | . | 1 | 33.3% | 2 | 66.7% | 3 | 100.0% |
CIN3 | 9 | 11.8% | 9 | 11.8% | . | . | 47 | 61.8% | 3 | 3.9% | 4 | 5.3% | 3 | 3.9% | 1 | 1.3% | 76 | 100.0% |
Adenocarcinoma | . | . | . | . | . | . | . | . | 1 | 100.0% | . | . | . | . | . | . | 1 | 100.0% |
Total | 224 | 1.9% | 102 | 0.9% | . | . | 115 | 1.0% | 10 | 0.1% | 5 | 0.0% | 15 | 0.1% | 11266 | 96.0% | 11737 | 100.0% |
NOTE: Histopathological outcome from T83x taken into account. |
This list includes only one diagnosis (the highest ranking) per person, applies to both Cyt and Pad. |
* Harmonization of PAD codes classification between analysis registry and process registry has been carried out. PAD Class 0 (non diagnostic, unreasonable diagnosis) is excluded, and next PAD counts instead. |
The classes 2a, b, c and 3a (suspected premalignant, pre-malignant UNS, HPV, suspected malignant) are grouped into 'Other'. |
Process Registry's Class 1 (benign), 2d (CIN1) and 3b (manifest cancer) have all been introduced without exception. Some codes that occur beyond the scope of the process registry has been added to the different categories. |
Snomed codes in the category Cancer: |
---|
M80703, M81401 |